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Abstract
To date, the reliability of induction of a depressive-like state using chronic stress models is confronted by many
methodological limitations. We believe that the modifications to the stress paradigm in mice proposed herein
allow some of these limitations to be overcome. Here, we discuss a variant of the standard stress paradigm, which
results in anhedonia. This anhedonic state was defined by a decrease in sucrose preference that was not exhibited
by all animals. As such, we propose the use of non-anhedonic, stressed mice as an internal control in experimental
mouse models of depression. The application of an internal control for the effects of stress, along with optimized
behavioural testing, can enable the analysis of biological correlates of stress-induced anhedonia versus the
consequences of stress alone in a chronic-stress depression model. This is illustrated, for instance, by distinct
physiological and molecular profiles in anhedonic and non-anhedonic groups subjected to stress. These results
argue for the use of a subgroup of individuals who are negative for the induction of a depressive phenotype
during experimental paradigms of depression as an internal control, for more refined modeling of this disorder in
animals.
Keywords: animal model of depression chronic stress, sucrose test, anhedonia, antidepressant treatment, gene
expression profiling, neuroinflammation, mouse
Introduction
Depression is projected to become the second most com-
mon cause of disability worldwide by 2015. Depression as
a major health issue is illustrated by its death-toll, which
currently claims more lives per year than road-traffic
accidents [1-4]. At the same time, there is an obvious
need for an improvement in the treatment of depression,
as up to 45% of depressed patients do not show improved
mood after advanced therapy and 15% of patients do not
respond to any antidepressant therapies [5]. The Diag-
nostic and Statistical Manual, Fourth Edition (DSM-IV)
defines depression by the presence of at least one of two
core symptoms: anhedonia; a decreased ability to experi-
ence pleasures, and depressive mood; lasting minimally 2
weeks [6,7]. Since anhedonia, on the one hand, is a cardi-
nal phenomenon of depressive disorders, and on the
other, can be evoked in rodents, the hedonic deficit
might be considered as a primary feature to be addressed
in pre-clinical models of depression. Coping and cogni-
tive deficits, low exploratory motivation, circadian and
sleep disturbances, aggressive and anxiety traits,
decreased sexual and increased submissive behaviour,
social avoidance, deterioration of the coat state and other
changes, which can be evoked in animals, with some con-
siderations [8] are regarded as parallels of subsidiary
depressive symptoms [9,10].
The aim of this review is to analyze the major metho-
dological drawbacks in mouse models of depression
with a focus on its principal feature, anhedonia, in a
chronic stress paradigm, and to share with the reader
several procedural modifications resulting from our own
experiences with a chronic stress model in C57BL/6N
mice. We believe that the changes to methodology pro-
posed here provide important advances in modelling the
neurobiological basis of depression in rodents and that
their implication can help develop more effective thera-
peutic strategies.
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chronic stress paradigms
The chronic stress paradigm is considered to have a
greater aetiological relevance and face validity in
mimicking depression than other animal models, and
therefore has become one of the most broadly used pre-
clinical paradigms of this disorder [11-14]. The first
experiments using this model were undertaken by Katz
and colleagues in rats, and involved rotating stressors
applied over 21-days [15]. These procedures were later
modified by Willner resulting in higher length of experi-
ment and lower severity of stressor [16]. These experi-
ments resulted in a decreased preference for, and intake
of palatable solutions such as sucrose or saccharine.
This was defined as stress-induced anhedonia. This
anhedonic state was accompanied by an increase in the
thresholds required for intracranial self-stimulation and
was reversed by anti-depressants, but not by neurolep-
tics or anxiolytics [13,17]. By now, a number of variants
of chronic stress procedures had been proposed in both
rats and mice and had been shown to evoke, in addition
to anhedonia, the subsidiary depressive-like features
mentioned above [18-31].
Regrettably, a number of studies revealed inconsistencies
in the induction of hedonic deficit in chronic stress models
in both rats and mice [32-35]. For example, in one study,
Wistar and PVG hooded rats were subjected to chronic
mild stress; stressed animals of both lines showed “unreli-
able” decreases in sucrose intake, which were “inconsis-
tent” over time. None of stressed animals showed a
decrease in the intracranial self-stimulation, evaluated by
50% of maximal response rate in the rate/frequency func-
tion [36]. Problems with reproducibility could also be due
partly to the limited accuracy of the sucrose test, which, in
its current state, does not have sufficient resolution to dis-
criminate between anhedonic and non-anhedonic indivi-
duals within a stressed population [37-39]. In addition,
some of multi-disciplinary studies, using anhedonic
chronic stress models of depression, have resulted in
abstruse and contradictory outcomes, and failed to define
a consistent molecular, neuroanatomical and physiological
phenotype in either rats or mice. Data on their locomo-
t i o n ,a n x i e t y ,e x p l o r a t i o n ,a n do t h e rb e h a v i o u r so f t e n
demonstrated paradoxical and conflicting behavioural
changes; many of them showed discrepancies between the
behavioural phenotype of chronically stressed animals and
human symptoms of depression. Together, controversies
with reproducibility of stress-induced anhedonia, defined
by sucrose preference data and identification of biological
correlates of depression greatly limit the value of this
method to model pre-clinical depression [40].
Apart from methodological problems, application of
the chronic stress approach has encountered some con-
ceptual drawbacks. The most obvious is that in
previously proposed models, all effects observed in
groups of chronically stressed animals with signs of a
decreased sensitivity to reward, are attributed to an
hedonic deficit. It is important to note that stress alone
can evoke a number of physiological alterations, which
are not associated with a depressive-like behavior and
anhedonia. With the originally proposed models and
their analogues it was not possible to correlate findings
obtained in chronically stressed animals with anhedonia,
thus, specific biological correlates of hedonic deficit
could not be addressed.
Studies with our new model of stress-induced anhedo-
nia suggest that unresolved methodological difficulties in
measuring behaviour in chronically stressed animals may
be the origin of the above problems. Here, we present
data obtained across several experiments, which reveal
the major sources of behavioural artifacts in chronic
stress mouse models of depression. These data enable us
to propose several changes to the accepted methodology
which are validated by both behavioural and molecular
correlates of anhedonia.
Anhedonia is exhibited by a subgroup of animals in
chronic stress paradigms
Numerous findings show a remarkable inter-individual
variability in animals’ responses to stress [9,13,41-43].
Using a principle of the isolation of responders and non-
responders, we have established a mouse model of stress-
induced anhedonia with an internal control for the effects
of stress alone [44]. A four week chronic stress paradigm,
comprised of exposing male 3-months-old C57/BL6N mice
to tail suspension and restraint stress in different proce-
dural variants resulted in a decrease of preference to 1%
sucrose solution by ≤ 65% in 50-70% of animals [[44-49];
Figure 1]. It was shown that sucrose preference is similar
in control, non-anhedonic and anhedonic mice before the
onset of stress. At the end of the stress induction period
sucrose preference and intake markedly decrease and are
replaced by an increase in water consumption.
Recent studies in chronically stressed mice and rats
have shown similar partial depressive-like outcomes
([21-25]; see Table 1). Resilience or susceptibility to
stress-induced anhedonia and/or other physiological par-
allels of depressive-like state in newly developed models
was found to correlate with distinct regulation of meso-
limbic dopamine circuits, excitability of dopamine neu-
rons of ventral tegmental area [21,50], activity of the
medial prefrontal cortex, nucleus accumbens and amyg-
dala [21,51], differential expression of neuropeptide Y,
transcription and factors markers, immediate early genes,
a dysfunction in the GABAergic system and AMPA-
mediated transmission [21,23,51-57], as well as changes
in learning capacities including working memory [56,57]
and hippocampal neurogenesis [58].
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ence to stress-induced decreases in sucrose preference
observed in these, and our, paradigms suggest that this
phenomenon is typical, even for inbred lines of animals
[21,56,59-63]. A variety of potential mechanisms may
underlie this phenomenon: 1) pre-natal and early environ-
mental factors [64] epigenetic mechanisms consisting in
DNA and chromatin modifications, histone acetylation
and methylation [65,66] and switches and error-prone
DNA replicates [67]; 3) large-scale organization of gene
expression levels and multigenic trait mechanisms [68,69],
7) posttranslational regulation of proteins [70]. Generally,
preservation, even in genetically homogenious lines of ani-
mals, of inter-individual variability of physiological para-
meters allows one to develop hypotheses regarding its
importance as a biological factor of adaptation and survi-
val, especially relevant in a stressful environment, which
may be mediated by specific biological mechanisms.
Physiological features of stress and stress-induced
anhedonia in mice
Original protocols using C57BL/6N mice for studying
emotionality, locomotion, exploration, cognition and
other functions [38,71,72] were modified in order to pre-
clude behavioural artifacts in testing chronically stressed
mice (see below). So-called “mild” testing conditions
applied with these modifications, were aimed at the
reduction of stress in animals during their testing and
therefore preventing the occurrence of stress-induced
hyperlocomotion. Behavioural features of anhedonic and
non-anhedonic mice are summarized in the Table 2. In
contrast to non-anhedonic animals, anhedonic mice
revealed increased floating during the forced-swim test
and immobilization behaviour in the tail suspension test,
reduced exploration of a novel environment and object,
impaired hippocampal-dependent performance in the
step-down passive avoidance, Y-maze and contextual fear
conditioning tasks, and disrupted burrowing behaviour in
the food displacement test. A development of the latter
deficit, as well as of behavioural despair and disruption of
contextual learning were precluded by chronic antide-
pressant treatment in our model [[46], Tokarski et al.:
Impaired hippocampal plasticity in mice with hedonic
deficit, induced by chronic stress, unpublished)]. The
above listed changes in behaviour are considered as ana-
logues of those seen in patients, diminished interest in
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Figure 1 Chronic stress results in decreased sucrose preference in a subgroup of mice. After initial increase in sucrose preference on the
3rd week of stress, by the termination of a 4-week stress, a cohort of mice display a prominent decrease in sucrose preference. Mice subjected
to chronic stress were split into anhedonic and non-anhedonic subgroups according to the criterion of 65% preference for sucrose solution (see
the text), Reproduction of this material is permitted by Macmillan Publishers Ltd.
Table 1 Partial depressive-like outcomes in chronic stress models of depression
Stress Laboratory strain Measure of a depressive-like state Susceptibility rate Reference
6-week CMS Wistar rats Low sucrose preference 51.5% [25]
5-week social stress CD1 mice Increase of CORT, Low sucrose preference 20% [24,57]
7-week CMS Wistar rats Low sucrose intake 50-70% [23,54-56]
10-day social defeat C57BL/6J Social avoidance, Low sucrose preference 50-70% [21,50-53,58]
7-week unpredictable CMS Eleven common mouse strains Coat deterioration, Low sucrose preference Vary in different strains [22,41,60]
Recent studies identified susceptible and resilient subpopulations of chronically stressed mice defined by anhedonia occurrence in a sucrose test, deterioration of
a coat state, or an increase in basal CORT levels.
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memory [6,7]. These symptoms were mimicked in pre-
clinical studies, many of which revealed the curative
effects of antidepressants[9,10,13].
As well as behavioural changes, we found specific phy-
siological abnormalities in anhedonic animals; a lack of
ex-vivo LTP induction capa c i t yi nt h eC A 1a r e ao ft h e
hippocampus during high frequency stimulation proto-
cols, elevated duration of REM sleep and home cage
hyperlocomotion (Table 2). Chronic treatment with an
SSRI precluded stress-induced disruption of LTP induc-
tion in hippocampal slices. This data correlates with
human studies showing that impaired hippocampal
function and synaptic plasticity are sensitive to antide-
pressant treatment [73,74]. The augmentation of REM
sleep and disturbances in diurnal rhythms observed in
clinical studies and animal models of depression are
thought to be characteristic of clinical depression
[3-7,18,20]. In particular, depressed patients exhibit a
high percentage of REM sleep when compared to other
neuropsychiatric disorders with shared pathophysiology.
At the same time, many changes in animals were found
to occur in stressed animals irrespectively of the presence
of hedonic deficit: hyperlocomotion observed in brightly
illuminated open field, hypoactivity in the dark open
field, increased scores of anxiety-like behaviour in the
dark/light and elevated O-maze tests, high scores of
aggressive behaviour and loss of body weight (Table 2).
Increased scores of anxiety, aggressive behaviour, loco-
motor inhibition and behavioural invigoration are also
well documented in humans and are thought to be the
result of stressful experiences [3-7,28,31,75].
In the present model, stress-induced loss of body weight,
high scores of anxiety and locomotor diturbances are
comparable in anhedonic and non-anhedonic mice that
might be regarded as an indication of similar impact of
the stress in these animals. Data concerning anxiogenic-
like changes in the O-maze in C57BL/6J mice with and
without social avoidance and anhedonia evoked by social
defeat stress [21] are in line with our findings. In this
study, no difference in body weight between two groups
was observed at the time point of experiment, when signs
of elevated depressive- and anxiety-like behaviour were
revealed in stressed animals. The CD1 mice, either resili-
ent or susceptible to chronic social stress, as measured by
changes of basal CORT levels and sucrose preference,
showed no alterations in body weight [57]. In studies on
other mouse lines, a manifestation of stress-induced
depressive-like features correlated with a loss of body
mass [13,23,41,60]. This suggests that species-specific
Table 2 Physiological correlates of stress and stress-induced anhedonia in our model
Physiological variable Anhedonic
Changes vs.
control
Non-anhedonic
Changes vs. control
Reference
1. Floating in forced swim test Increased Not changed [38,44,45]
2. Immobilization in
tailsuspension test
Increased Not changed [39,47]
3. Novelty exploration Decreased Not changed [44]
4. Burrowing behaviour Decreased Increased [38,39]
5. Contextual memory in
passive avoidance
Decreased Not changed [38]
6. Contextual fear conditioning Decreased Not changed [Tokarski et al. Impaired hippocampal plasticity in mice with
hedonic deficit, induced by chronic stress (unpublished)]
7. LTP in the CA1 area of the
hippocampus
Disrupted Not changed [Tokarski et al. Impaired hippocampal plasticity in mice with
hedonic deficit, induced by chronic stress (unpublished)]
8. REM sleep Increased Not changed [46,48]
9. Home cage activity during
dark phase
Increased Not changed [47]
10. Anxiety-like behavior in O-
maze and dark-light box
Increased Increased [38,44,108]
11. Open field locomotion
under modest lighting
Increased Increased [38,44,108]
12. Aggressive behavior Increased Increased [[95], unpublished data]
13. Auditory fear conditioning Not changed Not changed [Tokarski et al. Impaired hippocampal plasticity in mice with
hedonic deficit, induced by chronic stress (unpublished]
14. Body weight Decreased Decreased [38,39,44-49]
Eight out of fourteen evaluated physiological variables had differential changes in anhedonic and non-anhedonic animals, as compared to control. Remaining
parameters were either not altered in these groups, or were changed in the same direction, suggesting that not all physiological consequences of stress can be
attributed to anhedonia in the employed model.
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underlie a distinct relationship between anhedonia and
body weight. In line with our results, both anhedonic and
non-anhdonic Wistar rats in the chronic stress model
were found to have similarly decreased body weight [25].
We believe that the absence of differences in body mass in
our model between anhedonic and non-anhedonic mice
may be caused by the ‘ceiling effect’ of stress on physical
parameters in a specific strain. Similar values of body
weight in subgroups of stressed mice can be an important
factor, which prevents significant confounds in the beha-
vioural comparison of anhedonic and non-anhedonic
mice. Should body weight vary between these groups,
their comparison in behavioural tests based, for example,
on the measurement of liquid intake and foot shock appli-
cation is likely to be compromised by distinct metabolic
features and a response to an electrical stimulation.
The latest literature suggests a link between common
inflammatory factors, loss of body weight and sickness
behaviour - a state which is related to anhedonia. In the
light of recent identification of inflammatory factors,
which underlie both sickness behaviour and depression
[76], it can be speculated that stress-induced decreases in
body weight, in addition to classical mechanisms of hor-
monal secretion and sympathetic activation, might be
mediated by activated inflammatory pathways involved in
the pathogenesis of anhedonia. Of note, in our model
stressed, anhedonic mice showed disrupted burrowing
behaviour that we believe to be related to both lesions of
the dorsal hippocampus and sickness behaviour
[38,39,77]. While, in our studies, both susceptible and
resilient animals showed a robust decrease in body
weight, a potential contribution of inflammatory factors
to this consequence of stress could be an interesting
question to be addressed experimentally.
Interestingly, elevated anxiety was found in stressed ani-
mals irrespective of the occurrence of hedonic deficit, sup-
porting the clinical view of the comorbidity of anxiety and
depression, where core pathogenetic mechanisms are
thought to be distinct [78,79]. These distinct mechanisms
are used to separate anxiety from anhedonia in animal
models of depression. Of importance, a stress-induced
anhedonic state was found to be selectively associated
with depressive-like features, which were not observed in
stressed non-anhedonic animals. In contrast, pathological
changes that are common for a broad spectrum of stress-
related disorders besides depression, e.g., behavioural invi-
goration, and high anxiety are shared between stressed
mice with and without depressive-like features. The fact
that anhedonic mice display depressive-like traits which
are not detected in the non-anhedonic group speak in
f a v o u ro ft h ef a c ev a l i d i t yo ft h ee m p l o y e dm o d e la sa
model of depression at the first instance, and argue for the
adequacy of the latter group as a proper control for the
effects of stress that are not associated with a depressive-
like state. Several groups who have employed a similar
approach have obtained comparable outcomes that further
support our original findings concerning differential phy-
siological profiles of animals resilient and susceptible to
stress-induced depression (Table 3).
Identification of molecular correlates of stress and stress-
induced anhedonia
Altered functional activity within the hippocampal for-
mation is thought to be important hallmark of stress and
a depressive-like state [80,81]. Utilizing the hippocampi
of control versus stressed anhedonic and non-anhedonic
mice, gene expression profiling has been performed using
Illumina technology (IntegraGen, Evry, France) and the
Ingenuity Pathway Analysis program (Ingenuity Systems,
Redwood city, CA, USA). Anhedonic and non-anhedonic
mice displayed substantial changes in clusters of genes
Table 3 Features of resilience and susceptibility to stress-
induced depressive state in animal models
Physiological variable Susceptible Resilient
Sucrose intake/preference Decreased
[21-25]
Not changed
[21-25]
Behavioural despair Increased
[23,25]
Not changed
[21]
Not changed
[21,23,25]
Social avoidance Increased
[21,22]
Not changed
[21,22]
Novelty exploration Decreased
[21,22]
Increased [25]
Not changed
[21,22]
Increased [25]
Contextual memory Decreased [24]
Not changed
[23]
Not changed
[23,24]
Working memory Decreased [24] Not changed [24]
Coat state and self-
grooming
Impaired
[22,24]
Not changed
[22,24]
Anxiety-like behavior Increased
[21,22,24]
Not changed
[25]
Increased
[21,22,25]
Not changed [24]
Body weight Decreased
[21,22,25]
Not changed
[21-24]
Decreased
[21,22,25]
Not changed
[21-24]
Social hyperthermia Increased [21] Not changed [21]
Stress-induced polydipsia Increased
[21]
Not changed
[21]
Circadian amplitude Dereased [21] Not changed [21]
Conditioned place
preference
Increased [21] Not changed [21]
Newly available models of depression which differentiate resilient and
susceptible cohorts of animals enable a distinction of their physiological
profiles. Original reports describing animal paradigms are quoted; in some
cases dependently on the measure taken and the strain used the outcome
varied within the same paradigm.
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tain various CNS processes (Table 4). While a detailed
analysis of the likely outcomes of the affected functions
on hippocampal physiology has not been performed, it is
interesting to note that some of the observed changes in
anhedonic mice are part of categories consisting of nega-
tive or inhibitory processes. These include such clusters
of functions classified with the Ingenuity Pathway
Analysis program, as impaired psychological processes,
coordination and memory, pre-pulse inhibition and long
term and synaptic depression. Genes related to neurolo-
gical disease and disorders, and to neurodegeneration are
also affected. For the non-anhedonic mice, the functions
with higher gene expression are important in such pro-
cesses as biogenesis, formation, growth and development
of cells, neurites and vesicles. Positive behaviour and
Table 4 Comparison of gene expression in anhedonic and resilient stressed mice versus non-stressed controls
Category Function Anhedonic Resilient
# Genes
Up
# Genes
Down
p-value # Genes
Up
# Genes
Down
p-value
Cellular Assembly and
Organization
transport of vesicles N.S. 41 4.22E-07
biogenesis of
cytoskeleton
N.S. 35 3 5.41E-06
morphogenesis of
neurites
N.S. 33 7.25E-06
formation of vesicles N.S. 25 2.04E-05
formation of filaments 11 13 4.47E-05 N.S.
formation of neurites 4 8 8.47E-05 N.S.
Behavior cognition 9 6 2.62E-03 57 1 2.97E-06
behavior 30 16 1.29E-04 N.S.
learning N.S. 48 1 2.13E-05
psychological process of
mice
23 10 2.49E-04 N.S.
memory 10 5 3.01E-04 N.S.
exploratory behavior of
mice
6 1 1.80E-04 14 5.37E-04
Cellular Movement movement of brain cells N.S. 30 1 3.40E-06
migration of brain cells N.S. 29 1 4.59E-06
Nervous System Development and
Function
development of neurites 18 4 1.67E-05 63 6.50E-06
development of axons 11 4 3.10E-05 34 1.35E-03
long-term potentiation 10 5 2.54E-03 50 3 1.60E-05
long term depression 6 3 5.95E-04 N.S.
synaptic transmission 13 6 2.77E-05 50 1.29E-04
prepulse inhibition of
mice
8 2 2.66E-06 N.S.
coordination of mice 5 2 9.73E-05 N.S.
memory 10 5 3.01E-04 N.S.
spatial memory of mice 5 3 3.96E-04 N.S.
neurological process 25 19 4.65E-08 107 4 1.30E-03
neurotransmission 17 7 6.95E-07 57 1.30E-04
Neurological Disease seizures N.S. 35 1 1.11E-04
dyskinesia N.S. 76 2 1.86E-04
Huntington’s disease 18 11 2.11E-06 75 1 2.06E-04
neurological disorder 42 41 2.36E-06 258 11 5.50E-03
neurodegeneration of
neurons
8 3 2.75E-04 27 6.10E-04
Gene expression data sets containing gene identity and corresponding expression values from an Illumina Technology analysis have been analyzed using the
Ingenuity Pathway Analysis program. Out of 4795 eligible genes, the analysis generated lists of the most significant biological functions that are likely to be
affected in anhedonic stressed or resilient stressed mice hippocampi, respectively. For selected detailed functions, the numbers of up-regulated and down-
regulated genes are shown, as well as the significance score of the change in expression calculated as p-value of a right-tailed Fisher exact test. N.S. indicates a
non-significant test (p-value > 1E-02)
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LTP are also affected.
Another study with our model revealed an overproduc-
tion of the enzyme COX-2 in the hippocampus of anhe-
donic that was not observed in the non-anhedonic group
(Strekalova and Steinbusch, in preparation). Pre-treat-
ment with a pharmacological blocker of this enzyme with
food carried out through the entire period of chronic
stress elicited similar antidepressant-like effects to those,
which were evoked by citalopram in this study (Table 5).
Both drugs prevented a stress-induced decrease in
sucrose intake and preference, behavioural despair and
impairment of cognitive deficit in the fear conditioning
paradigm. These data are in line with growing evidence
that along with monoamines, factors of inflammation
play a crucial role in the mechanisms underlying anhedo-
nia and depression [76,82-84]. Recently, it has been
established that pro-inflammatory factors induce not
only symptoms of behavioural sickness which resemble
an anhedonic state, but are also implicated in the patho-
genesis of major depression. We believe that altered pro-
duction of COX-2 specifically, and the pharmacological
sensitivity of the main read-outs in our model, can be
considered as an evidence for such a link.
Together, our data suggest distinct molecular correlates
of states of stress and stress-induced anhedonia in a pro-
posed model. Similarly, studies in a social defeat paradigm
in C57BL/6J mice demonstrated that susceptible and resi-
lient individuals, which are distinct in scores of social
avoidance and sucrose intake and preference, have differ-
ential levels of immediate early genes Arc and Zif268 in
the frontal cortex, BDNF in the hippocampus and the ven-
tral tegmental area and DeltaFosB in the nucleus accum-
bens [21,50-53]. Studies in Wistar rats showed distinct
expression patterns of BDNF and vascular endothelial fac-
tor in the hippocampus [23]. Differential expression of
AMPA receptors in the dorsal hippocampus was revealed
between resilient and susceptible individuals in a social
stress model in outbred mice [57]. Further studies are
required to address key pathogenetic gene expression fac-
tors of resilience and susceptibility to a depressive syn-
drome precipitated by stress; such studies are under way.
Limitations of the sucrose preference test in assessing
anhedonia in chronic stress paradigms
Several behavioural paradigms are currently used to mea-
sure sensitivity to reward in rodent chronic stress models.
These include consumption of palatable solutions, pro-
gressive ratio responding, intracranial self-stimulation,
novel-object place conditioning and conditioned place pre-
ference [36,61,85-87]. The sucrose/saccharine consump-
tion free-access paradigm is probably the most extensively
used method, as it is not too labour- or time-intensive, has
high throughput and aritifacts related to learning, anxiety
and locomotion are minimal with this model. Decreased
intake and/or preference for palatable solutions is an over-
all validated behavioural measure of hedonic deficit
[9-13,87]. Insufficient accuracy of the sucrose test in mice
is, however, one of the key difficulties in measuring beha-
viour in chronic stress models of depression [14,32,38,39].
In mice, the sucrose test can typically reveal the differ-
ences between groups, but not between individual animals,
and is generally considered to result in more variable out-
come than in rats. A variety of sucrose test protocols have
been proposed to overcome these inconveniences [88-93].
The species-specific physiological features of drinking
behaviour and physical artifacts in its evaluation are
believed to underlie the insufficient resolution of the
sucrose test in mice [14,32,35,39]. In a series of experi-
ments, we have identified factors of drinking behaviour in
C57BL/6N mice, which may essentially interfere with the
outcome of the standard free-choice, two-bottle sucrose
test paradigm (Table 6). First, we found that individual
mice of the tested strain showed a preference for drinking
at one or the other corner of the cage. This preference was
not related to any obvious external factors, e.g., source of
noise or lighting in the room, as consumption of highly
concentrated sucrose solution depended on its localization
either in the preferred or non-preferred bottle position.
Housing the mice with water on both sides of the cage
abolished the side preference in drinking behaviour in
some but not all animals. Switching the position of the
bottles containing water or sucrose solution halfway
through the test minimalised this confounding factor. Sec-
ond, in C57BL/6N mice, one-bottle water tests revealed
Table 5 Effects of COX-2 inhibitor in mice subjected to chronic stress
Changes versus non-stressed control Stressed drug naive Stressed Citalopram-treated Stressed treated with COX-2 blocker
Sucrose preference ↓ ↔↔
Sucrose intake ↓ ↔↔
Floating behavior ↑↔ ↔
Contextual fear conditioning ↓ ↔↔
Parameters of anxiety in elevated O-maze ↑↔ ↑
Percentage of anhedonic mice above 60% below 25% below 25%
Chronic treatment with a COX-2 inhibitor during the course of chronic stress counteracted the development of hedonic deficit, behavioural despair, increased
anxiety and cognitive impairment in a similar manner to citalopram. Arrows indicate an increase in the parameter (↑), a decrease (↓), or lack of significant
changes in comparison to non-stressed control mice (↔).
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peaks in drinking behaviour during the 10-hour test per-
iod. Interestingly, temporal patterns in water intake corre-
lated with mean volume of consumption. For example,
animals with a peak in water intake 7.5 h after the begin-
ning of the active phase of the animals’ cycle had signifi-
cantly higher values of total water intake than any other
g r o u p .T h e s ed a t as u g g e s tt h at when analyzing drinking
behaviour and sucrose preference, experiments should
cover the periods of maximal liquid intake in all animals,
as well as taking into account the relative parameters of
preference in choice paradigms, rather than of absolute
intake values. In addition, absolute consumption of palata-
ble liquids can often be confounded by changes in the
consumatory behaviour induced by deprivation of food
and water, acute effects of stressors, altered metabolic
needs in calories and water [32,34,35,37]. The greater var-
iation in values of absolute intake of sucrose solution in
comparison with those of sucrose preference, as shown by
significant differences in variation [38,85,87], additionally
define sucrose preference as a parameter, which is least
influenced by animals’ individual drinking patterns.
Our experiments on mice naive to the taste of sucrose
revealed remarkable diversity in animals’ reactivity to a
sweet taste, which ranged from almost no reaction to
excessive sucrose consumption. Repeated exposure to
sucrose abolished the first type of behaviour, suggesting
that neophobia could underlie this response. A single
pre-exposure of mice to concentrated sucrose, a proce-
dure developed in a course of our studies, precluded
large variability in their sucrose preference. In different
studies, with repeated sessions of the sucrose test, pre-
ference and intake of sucroses o l u t i o n sw e r ef o u n dt o
increase substantially, suggesting that the results of test-
ing in this paradigm depend on the animals’ previous
experience of sucrose consumption can increase sucrose
intake and preference up to ceiling values decreases
test’s sensitivity [38,47]. This undesirable effect can be
counter balanced by application of sucrose solutions of
descending concentrations [45].
Our results confirm the findings of others, which
demonstrate that in comparison to rats, mice generally
demonstrate lower values of sucrose preference and
sucrose intake, a pronounced neophobic behaviour dur-
ing the very first exposure to a sucrose solution, essen-
tial inter-individual variability in sucrose preference and,
especially, in absolute values of daily liquid intake
[11-13,87-93]. Together, the above data show that
s u c r o s ep r e f e r e n c ei sap a r a m e t e ro ft h es u c r o s et e s t
and is more appropriate than absolute sucrose intake for
the analysis of inter-individual differences in hedonic
sensitivity in mice. Further, bottle-position preference in
mouse drinking behaviour and neophobia together with
other factors, may be the cause of essential physiological
artifacts in evaluating the sucrose test.
Correcting for limitations in the sucrose preference test in
chronic stress-induced anhedonia
We have undertaken several procedural modifications in
order to eliminate the above behavioural artifacts. With
our proposed protocol, mice are given a free choice
between two bottles for 8-24 hours, one with 1%-sucrose
solution and another with tap water; the position of the
bottles in the cage is switched halfway through this per-
iod. At no point during or prior to this are mice deprived
of food or water. To minimize the spillage of liquids dur-
ing the sucrose test, bottles are filled in advance and kept
in an up-side-down position for at least 12 hours prior to
testing. In order to balance the air temperature between
the room and the drinking bottles, they are kept in the
Table 6 Factors of potential confounds in a free drinking two-bottle sucrose test
Own behavioral data Source of
confounds
Preventing of confounds in testing References
Sucrose solution intake is affected by a position of the bottle
on preferable or non-preferable side. Weeks of housing with
two bottles does not abolish side preference in drinking
behaviour
Side preference in
drinking
Switching of the bottles in a middle
of the test
[21,22,24,38,47,92]
Individual patterns of absolute water intake in a 10-h test Large individual
variability in daily
drinking patterns
Prolonged testing [38,47,89,92]
High variability in sucrose intake versus water intake in
sucrose-naïve mice
Neophobia Habituation to a sucrose solution
Sucrose preference as a measure of
hedonic sensitivity
[22,38,44,47,85,90-92]
Ceiling values of sucrose preference after massive experience
in sucrose ingestion
Sensitization to a
sucrose taste
Use of sucrose solution of low
concentrations
[24,38,47,87,88,93]
High inter-individual variability in absolute intake of liquids Inter-individual
differences in
metabolic needs
Use of a sucrose preference not
sucrose intake as a measure of
hedonic sensitivity
[25,38,44,47,85,87,92,93]
Studies revealed major sources of confounding factors in the commonly used mouse sucrose preference test. The application of testing conditions which
minimize their impact were shown to be benefitial in recently published literature.
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liquid leakage resulting from increased air temperature
and pressure inside the bottles, when they are filled with
liquids which are cooler than the room air.
The consumption of water, sucrose solution and total
intake of liquids is estimated simultaneously in the con-
trol and experimental groups by weighing the bottles. In
order to decrease variability in sucrose consumption
during the very first sucrose test (baseline measure-
ment), a day before, animals are allowed to drink a 2.5%
sucrose solution in a one-bottle paradigm for 2 hours.
The preference for sucrose is calculated as a percentage
of the consumed sucrose solution from the total amount
of liquid drunk by the formula:
Sucrose Preference = V (Sucrose solution)/V (Sucrose solution)+V(Water)×100%
We found that with this method, the error of mea-
surement does not exceed 0.1 ml. This appears to
greatly enhance the resolution of the test and more spe-
cifically assess hedonic state that takes into account
inter-individual variability.
Submissive traits predict stress-induced anhedonia in
C57BL6/N mice
A number of studies have shown that it is possible to pre-
dict inter-individual variability, in terms of the stress
response, by observing an animal’s baseline behaviour. Spe-
cifically, animals that show high anxiety [41,60,63], low
open field locomotion [30,94], freezing response in averse
conditions [42] and decreased exploratory behavior [25,43]
will often have a different stress response to their ‘normal’
littermates. This phenomenon is attracting the attention of
researchers and becoming broadly implemented in funda-
mental and industrial psychopharmacological research. In
our experiments, male social behaviour was shown to pre-
dict an individual susceptibility to stress-induced anhedonia
in mice: individuals with submissive social traits were found
to be more vulnerable to the anhedonic state [44-47]. Dur-
ing a 4-week stress induction period, anhedonia was found
to occur earlier in all submissive animals. In one study,
after only 3.5 weeks, 100% of submissive mice exhibited
lowered sucrose preference (< 65%) and matched a given
criterion of anhedonia; only 16.6% of aggressive mice that
had undergone the same stressors exhibited the criteria for
anhedonia at this stage [44]. The ethological analysis of
more than thirty parameters of social behavior in a resi-
dent-intruder test, performed with our stress model,
revealed reduced scores in aggressive and dominance beha-
viours in mice predisposed to stress-induced anhedonia
[95]. A number of studies have shown that animals with
subdominant behavioural characteristics will most fre-
quently exhibit low sucrose preference and anhedonia in
similar social defeat models [14,21,62,96-99]. The variability
in social traits, which is related to the animal’si n d i v i d u a l
ability to cope with environmental stressors, can be consid-
ered as a biological factor of species’ adaptation and survi-
val. It can be of even higher significance when animals are
placed in stressful conditions and, therefore, of evolutionary
advantage in general. Recently identified epigenetic molecu-
lar mechanisms are suggested to underlie the distinct
response of individual animals to environmental challenges
[9,94,100].
In our stress paradigm, a resident-intruder test was
adapted from the procedure originally proposed by Krsiak
and co-authors [101,102]. Initially, the protocol employs a
qualitative criterion of differentiation into submissive vs.
non-submissive mice, defined as an absence or presence of
attacks towards the partner, respectively. In this test, male
mice (C57/BL6N - intruders), after being isolated for 3-5
weeks, and when confronted in a neutral cage with another
male mouse which had been group-housed (CD1 - resi-
dents), will either show aggressive (non-submissive), timid
(submissive) or social behaviour. Aggressive activities of
both resident and intruder are characterized by attack and
aggressive unrest, frequently accompanied by tail rattling.
Timid activities consist of alert posture, escape and defence
and are never accompanied by aggressive reactions
(attacks). Social behaviour includes social sniff and ‘climb
and follow’, this type of social behaviour excludes attacks
between the partners; in our study this behaviour was cate-
gorized as non-definable with regard to social submissive-
ness. A manifestation of submissive and aggressive types of
social behaviour in C57BL/6N mice was found to appear
irrespective of social traits of CD1 counter partners.
According to our data, testing procedures did not induce
depressive-like behaviours in the forced swim or sucrose
preference tests. Group-housing of male C57BL/6N mice is
known to result in aggressive behaviour between cage
mates that, importantly, enhances a variability in anxiety-
related and a number of other behaviours, as well as having
a significant impact on the stress response. We therefore
chose to test animals from experimental groups, using
them as intruders in a resident-intruder test, thus avoiding
the undesirable effects of group housing. While it is more
usual to analyze the resident animal in this paradigm, we
believe that our protocol of testing social behaviour
allowed us to preclude major artifacts in comparing ani-
mals from anhedonic and non-anhedonic groups.
Interestingly, in populations with an initially low percen-
tage of submissive animals (15-20%), all submissive mice
develop anhedonia. In populations with a high percentage
of submissive individuals (>50%), the percentage of non-
submissive (dominant or aggressive) animals susceptible
to anhedonia is significantly lower in comparison to a sub-
missive cohort of mice. Remarkably, social characteristics
of animal batches, such as a percentage of aggressive mice,
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stress. For example, changes in parameters such as sucrose
intake and preference, and total liquid intake during differ-
ent phases of the course of stress exposure were observed
over a several years in our lab, under identical experimen-
tal conditions [39,47]. For instance, in populations with an
initially low percentage of submissive animals, statistically
significant decreases in sucrose preference in the stressed
group occur at 3.5 weeks after introduction of the stressor.
Interestingly, in these animals, stress exposure causes an
increase in sucrose intake and preference at the beginning
of the stress procedure, and leads to a slight elevation of
water intake. In contrast, in experimental groups contain-
ing high percentage of submissive individuals (>50%) the
drop in sucrose preference is detected much earlier, after
2.5 weeks of stress; these animals demonstrate an increase
in sucrose intake and sharp elevation of water consump-
tion [Figures 1 and 2B; [44,48]]. Over our 6 years of study-
ing them, the C57BL/6N strain of mice have shown a
remarkable range, from 15-85%, in the proportion of indi-
viduals with submissive social characteristics.
Taken together, these data suggest that initial popula-
tions with unbalanced social traits could lead to different
susceptibilities in terms of the chronic stress model, and
may be one of the sources of unstable reproducibility. Our
studies have shown that, in terms of development of anhe-
donia, no differences in initial open field, exploratory rear-
ing, step-down avoidance, novel object or anxiety-like
behaviours were exhibited between mice from anhedonic
and non-anhedonic groups [38,39,44-49]. These data are
not always consistent with results published by other
groups, which, for example, found a correlation between
initial elevated anxiety-like behaviour and enhanced
stress-response [41,63]. The discrepancy between this and
our data could be explicated by differences in substrains
used and protocols of testing anxiety-like behaviours.
Others, however, have largely supported our findings [21]
by showing a lack of differences in various behavioural
parameters and baseline sucrose intake and preference
between animals from anhedonic and non-anhedonic
groups. We believe that in general, balancing of percen-
tage of animals upon a parameter, which is predictive for
individual susceptibility to a depressive-like state in any
particular chronic stress depression model, can greatly
help increase its reliability, especially when the testing of
potential anti-depressant treatment is involved.
Identifying and compensating for behavioural artifacts
caused by stress-induced hyperlocomotion
Hyperlocomotion as an increase of a distance traveled by
an animal over a time span is not uncommonly seen in
chronic stress experiments. On another hand, many stu-
dies using chronic stress models of depression showed
abnormal changes in rodents’ behavior, which contradict
well documented profiles of states of stress and depres-
sion in animals [13,14]. These changes are often called
“paradoxical” or “anomalous” since they are opposite to
the general known patterns of behavioural inhibition,
impaired coping and increased scores of anxiety observed
in patients with stress-related disorders and respective
pre-clinical paradigms. For example, the chronic mild
stress procedure was shown to not affect or to increase
anxiety-like behaviours, i.e. time spent in anxiety-related
areas of the elevated plus maze and dark/light box and to
reduce immobility time in forced swimming tests in mice
[103-107]. Exposure to a chronic stress was shown to
lead to increased ambulation in the open-field test in
mice [28]. Taking into account the aforementioned data
from the literature, as well as our own results, which
demonstrated drastic increases in speed and total path in
the open-field, anxiolytic-like changes in the dark/light
and elevated O-maze paradigms alone with reduced
duration of floating in the forced swim test in chronically
stressed mice (Table 7), we suggest this hyperlocomotion
is an non-specific consequence of chronic stress and is
triggered by the stressful procedure of testing. Thus,
reduction of the stress impact of testing conditions, e.g.,
diminishing light intensity should be considered as an
important pre-requisite of behavioral analysis in the
chronic stress models. These findings were implemented
in our behavioural protocols in which we were using
“mild” conditions of testing with low stress impact [108].
We believe this was a key factor in enabling us to identify
consistent behavioural correlates of anhedonia in our
model.
Recent studies described similar phenomenon in sev-
eral laboratory mouse strains [109-111]. While various
effects of chronic stress on general locomotion in rodents
were described [34,96,112-114,1115], lighting conditions
employed during testing were reported to be a significant
factor of general activity in the stressed animals
[116-118]. We believe that stress-induced hyperactivity is
a typical phenomenon in chronically stressed C57BL/6N
mice and is potentially a major source of artifacts in
behavioural analysis of chronic stress data and that this
can explain previously reported contradictions resulting
from similar paradigms.
Increased liquid intake and home-cage locomotion in
anhedonic versus non-anhedonic mice: indication of an
elevated stress-response?
Stress-induced increases in sucrose and water intake in
mice and rats exposed to a prolonged stress have been
documented elsewhere [21,34,119,120]. Parallels have
been made in the literature between these signs of ele-
vated consummatory behaviour in stressed animals and
other indicators of behavioural invigoration, e.g.
enhanced swim scores, excessive grooming, increased
Strekalova et al. Behavioral and Brain Functions 2011, 7:9
http://www.behavioralandbrainfunctions.com/content/7/1/9
Page 10 of 18activity in anxiety paradigms and in other tests [121-123].
Apart from general behavioural invigoration and an
increase in consumption scores, the augmentation of
general liquid intake observed in chronic stress para-
digms is believed to result from a stress-induced polydip-
sia, increased metabolic needs, diabetes mellitus and
altered hormone secretion from both the hypothalamus
and hypophysis [21,124,125]. Our studies revealed drastic
changes in water and sucrose solution consumption as
well as home cage locomotion during the course of the
chronic stress procedure in C57BL/6N mice. Analysis of
animals from the anhedonic and non-anhedonic groups
at different phases of stress, and after its termination
revealed distinct patterns of dynamics within these para-
meters [39,44,45,47].
Our extensive experience with the chronic stress
model of depression has repeatedly shown that
anhedonic mice develop increased sucrose preference
and intake between days 14-21 of a 28 day paradigm.
This effect is pronounced ando fs i g n i f i c a n td u r a t i o n
in anhedonic animals but is transient in non-anhedonic
groups (Figure 2, adapted from [45]). Similarly, total
liquid intake is also increased in both groups but anhe-
donic animals maintain this change over a longer per-
iod than their non-anhedonic littermates. The
increased water intake in anhedonic animals lasts for
several weeks after the termination of chronic stress;
non-anhedonic animals, however, exhibited normal
liquid consumption during the after-stress period (Fig-
ure 3; adapted from [45]). Of note, chronic administra-
tion of antidepressants citalopram and imipramine,
applied during and after chronic stress, reduced stress-
induced increase in water consumption in our model
[45].
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Figure 2 Differential stress-induced changes in the sucrose test parameters in anhedonic and non-anhedonic mice. (A) Sucrose
preference in the anhedonic group is significantly lower than in non-anhedonic and control mice after 2.5, 3.5 and 4 weeks of stress. (B)
Sucrose intake in the anhedonic group is significantly increased after 2.5 weeks of stress and significantly decreased after 3.5 weeks of stress (vs.
non-anhedonic group) and after 4 weeks of stress (vs. control and non-anhedonic group). Non-anhedonic mice show elevated sucrose intake
after 2.5 and 3.5 weeks of stress. (C) Water intake is elevated in the anhedonic animals after 2.5 - 4 weeks of stress (vs. control and non-
anhedonic group). In the non-anhedonic group; water intake is increased after 2.5 weeks of stress as compared to control. (D) Total liquid intake
is elevated both in the anhedonic and in non-anhedonic animals after 2.5 and 3.5 weeks of stress (vs. control group). After 2.5 weeks, anhedonic
mice show significantly higher total liquid intake than non-anhedonic mice. Parameters of the sucrose test are expressed as a percentage of the
mean values of the control group, and compared between anhedonic (dashed line) and non-anhedonic (plain line) groups during a 4-week
stress procedure as mean ± (SEM) (*p < 0.05 vs. control group; #p < 0.05 vs. non-anhedonic group; Mann-Whitney).
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group was paralleled in our paradigm by sharp increases
in home-cage horizontal activity, which was not observed
the non-anhedonic group [47]. The latter behaviour was
studied using the System and software for Automatic
Measurement of Animal Behaviour (SAMAB), where
mice were housed individually in specialized cages with
infrared detection of horizontal movement.
Mean duration of movement was significantly elevated,
in anhedonic animals only, during the dark phase of the
day/night cycle between days 14 and 21 during the stress
procedure and for at least 14 days after termination of
the procedure (Figure 4A); no differences between the
groups are observed during the light phase (Figure 4B).
While the nature of the elevated intake of palatable solu-
tions during chronic stress is unclear, several reports sug-
gest that consumption of sweetened solutions can evoke
an antidepressant-like effect in rodents [13]. Interestingly,
mice from a group susceptible to stress-induced social
avoidance/anhedonia were shown to have higher scores of
conditioned place conditioning in comparison to resilient
mice [21]. This led to speculation that enhanced sucrose
Table 7 Identifying and compensating for behavioural artifacts caused by stress-induced hyperlocomotion
Anxiety-like behavior Floating in FST Open field locomotion
Standard protocol Mild protocol Standard protocol Mild protocol Bright/modest lighting Weak lighting
Short stress ↑↑ ↔ ↔ ↔ ↔
Chronic stress ↓↑ ↓↑ ↑ ↔
Chronic stress + diazepam ↑↑↔
Reduction in illumination, application of “mild” testing conditions or bolus diazepam injection preclude hyperlocomotion and “anomalous” behaviour in anxiety
and forced swim tests in chronically stressed mice. Mice subjected to short stress (1 week duration) do not exhibit “anomalous” behaviour. Arrows indicate an
increase in the parameter (↑), a decrease (↓), or lack of significant changes in comparison to non-stressed control mice (↔).
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Figure 3 Dynamics of the sucrose test parameters recovery in anhedonic and non-anhedonic mice. Parameters of the sucrose test were
expressed as a percentage of mean values of the control group, and compared between anhedonic (dashed line) and non-anhedonic (plain
line) groups during a 4-week stress procedure (*p < 0.05 vs. control group; # p < 0.05 vs. non-anhedonic group; Mann-Whitney). (A) Sucrose
preference in the anhedonic group is significantly lower than in the non-anhedonic and control mice throughout the entire experiment. (B)
Sucrose intake in the anhedonic group is significantly decreased after the termination of stress (vs. control and non-anhedonic group) and
during week 1 of the stress-free period (vs. control group). (C, D) Water consumption and total liquid intake are elevated in the anhedonic
animals up to 3 weeks after termination of stress as compared to control, and up to 2 weeks when compared to non-anhedonic mice. Data are
expressed as mean ± (SEM).
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might be “adaptation” to stress at its early stages. As such,
their increase in mice from an anhedonic group might
reflect a “hyperadaptation” to stress in this population, and
that the development of anhedonia at the late stage of
stress can manifest itself as a state of a “distress” in this
subgroup.
Both pronounced elevation of water intake and
enhanced home cage locomotion in anhedonic animals
may result from general sympathetic activation, induced
by chronic stress, and thus, reflect a pronounced
response to stress in these animals [21,126]. Our results
also suggest that stress-induced anhedonia in the current
mouse model is accompanied by an altered pattern of the
day/night activity, which correlates with compromised
sleep-wake patterns in depressed patients [127], and
which is not seen in stressed animals without hedonic
deficit. These data are in line with other studies which
found stress-induced hypertherimia and a decrease in cir-
cadian amplitude in a subgroup of mice with a depres-
sive-like state in a social defeat model [21]. Together,
differential patterns of liquids intake and home-cage
locomotion in anhedonic versus non-anhedonic mice
may be reflective of a higher stress susceptibility in the
first cohort of animals.
The effects of citalopram in anhedonic and non-
anhedonic mice
Recent studies suggest that chronic SSRI treatment in
mice resilient and susceptible to social defeat stress exerts
distinct physiological and molecular effects on the ventral
tegmental area and the medial prefrontal cortex
[23,53,54,128,129]. In line with these findings, pharmaco-
logical validation of a proposed model of stress-induced
anhedonia with a “post-stress” administration of citalo-
pram demonstrated its differential effects in anhedonic
and non-anhedonic groups. In one of the studies, exposure
of animals to chronic stress was followed by citalopram
delivery via the drinking solution (15 mg/kg/day) for four
weeks. Sucrose preference and body weight were moni-
tored weekly in control, anhedonic and non-anhedonic
mice [45]. Sucrose intake and preference increased in cita-
lopram-treated, but not non-treated anhedonic mice on
the 4th week of the dosing schedule; non-anhedonic and
control mice showed no changes in sucrose preference at
any time point (Figure 5A, adapted from [45]). Multiple
regression analysis showed that restoration of a preference
for sucrose in the anhedonic group was mostly due to a
several fold elevation of sucrose ingestion, a phenomenon
typical for prolonged treatment with antidepressants of
various classes [11-14]. Interestingly, while at this time
point of the experiment, mean sucrose consumption in
the non-treated anhedonic group was not different from
the values of non-treated control and non-anhedonic
groups, citalopram essentially affected sucrose intake
exclusively in anhedonic animals (Figure 5B). In the forced
swim test, anhedonic mice treated with an antidepressant,
demonstrated a decrease in duration of floating behaviour,
which was elevated in the non-treated anhedonic group.
Of note, chronic administration of citalopram did
not affect floating of the non-anhedonic animals and non-
significantly elevated this parameter in non-stressed con-
trol mice. Together, these data suggest that the occurrence
of a depressive-like state is a pre-requsite of animals’ sensi-
tivity to the action of antidepressants in a chronic stress
paradigm. More studies are required to elucidate the phy-
siological basis of selective effects of citalopram on depres-
sive-like features in stressed anhedonic mice.
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Figure 4 Anhedonic mice display lasting increases in home cage activity during the dark phase of the day. (A) During the dark phase of
the diurnal cycle, mean time of horizontal movement of the anhedonic group (dashed line) is significantly elevated during 2nd-4th weeks of
stress, and during weeks 1 and 2 after the termination of the stress procedure, as compared to the non-anhedonic (plain thick line) and control
(plain thin line) groups (*p < 0.05 vs. control group and # p < 0.05 vs. non-anhedonic group; Mann-Whitney). This parameter does not change in
the non-anhedonic group throughout the entire experiment (p > 0.05 vs. control group). (B) During the light phase of the day, no difference
between the groups in home cage activity is observed (p > 0.05). Data are expressed as mean ± (SEM).
Strekalova et al. Behavioral and Brain Functions 2011, 7:9
http://www.behavioralandbrainfunctions.com/content/7/1/9
Page 13 of 1870
80
90
100
110
Before              1w                  2w                  3w                  4w
treatment
        Non-anhedonic
 Cit
NoT
P
r
e
f
e
r
e
n
c
e
 
f
o
r
 
s
u
c
r
o
s
e
,
 
%
f
r
o
m
 
c
o
n
t
r
o
l
60
90
120
150
180
Before              1w                  2w                  3w                  4w
treatment
        Non-anhedonic
Cit
NoT
 
I
n
t
a
k
e
 
o
f
 
s
u
c
r
o
s
e
 
s
o
l
u
t
i
o
n
,
%
 
 
f
r
o
m
 
c
o
n
t
r
o
l
70
100
130
160
190
Before              1w                   2w                   3w                  4w
treatment
        Anhedonic
NoT
Cit
*
*
*
*
§
§
§
I
n
t
a
k
e
 
o
f
 
w
a
t
e
r
,
 
%
 
f
r
o
m
c
o
n
t
r
o
l
75
100
125
150
Before              1w                  2w                  3w                  4w
treatment
        Non-anhedonic
 Cit
NoT
T
o
t
a
l
 
l
i
q
u
i
d
 
i
n
t
a
k
e
,
 
%
f
r
o
m
 
c
o
n
t
r
o
l
75
100
125
150
  Before              1w                  2w                  3w                  4w
treatment
        Anhedonic
 Cit
NoT
§
* *
*
*
§
§
*
T
o
t
a
l
 
l
i
q
u
i
d
 
i
n
t
a
k
e
,
 
%
f
r
o
m
 
c
o
n
t
r
o
l
SUCROSE PREFERENCE
SUCROSE INTAKE
WATER INTAKE
TOTAL LIQUID INTAKE
BODY WEIGHT
A
B
C
D
E
80
90
100
110
Cit
NoT
Anhedonic
Before            1w                2w               3w                4w
treatment
*
* *
*
§
§
§
§
B
o
d
y
 
w
e
i
g
h
t
,
%
 
f
r
o
m
 
c
o
n
t
r
o
l
75
100
125
150
Before              1w                  2w                  3w                  4w
treatment
        Non-anhedonic
 Cit
NoT
T
o
t
a
l
 
l
i
q
u
i
d
 
i
n
t
a
k
e
,
 
%
f
r
o
m
 
c
o
n
t
r
o
l
70
80
90
100
110
  Before              1w                  2w                  3w                  4w
treatment
        Anhedonic
 Cit
NoT
*
P
r
e
f
e
r
e
n
c
e
 
f
o
r
 
s
u
c
r
o
s
e
,
%
 
f
r
o
m
 
c
o
n
t
r
o
l
* * *
*
* *
§
60
90
120
150
180
Before              1w                  2w                  3w                  4w
treatment
        Anhedonic
Cit
NoT
§
*
*
*
I
n
t
a
k
e
 
o
f
 
s
u
c
r
o
s
e
 
s
o
l
u
t
i
o
n
,
%
 
f
r
o
m
 
c
o
n
t
r
o
l
80
90
100
110 Non-anhedonic
No T
Cit
Before           1w                2w               3w                4w
treatment
*
*
* * *
B
o
d
y
 
w
e
i
g
h
t
,
%
 
f
r
o
m
 
c
o
n
t
r
o
l
Figure 5 Effects of citalopram on sucrose test parameters and body weight in anhedonic and non-anhedonic mice. (A-E) Data are
expressed as a percentage of the control and presented as medians ± interquartile intervals. Plain lines indicate non-treated groups, dashed
lines indicate citalopram-treated groups. NoT: non-treated group; Cit: citalopram-treated group (*p < 0.05 vs. control group; § p < 0.05 vs.
citalopram-treated anhedonic mice).
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Page 14 of 18Experiments with various methods of citalopram admin-
istration indicated that in anhedonic animals, chronic
administration of drug reduced water intake, which was
enhanced in this group of mice, and did not affect this
parameter in the non-anhedonic animals (Figure 5C).
Interestingly, anhedonic animals from the citalopram-trea-
ted stressed group had a higher average body weight than
non-anhedonic animals from the same group (Figure 5E).
Citalopram restored the body weight of anhedonic mice
after the 1st week of post-stress treatment but did not
have such an effect in non-anhedonic animals. During
weeks 2-4, body mass of the latter group was lower,
although not significantly, than in control and citalopram-
treated anhedonic aniamls. Prior to citalopram treatment,
both anhedonic and non-anhedonic animals exhibited
s i m i l a rp a t t e r n so fw e i g h tl o s sc o m p a r e dt oc o n t r o l s .
Restoration of body weight by antidepressant treatment,
particularly citalopram, in animal models of depression
has been shown to to accompany recovery from a depres-
sive-like state [130]. The distinct effects of citalopram on
body weight in anhedonic and non-anhedonic mice may
be related to the metabolic differences between these ani-
mals: repeated experiments with our model have revealed
a general higher baseline body mass in anhedonic than in
non-anhedonic animals (Strekalova, unpublished results).
These results suggest that citalopram is capable of altering
a number of variables in anhedonic animals. This provides
more refined analysis of the effects of antidepressant treat-
ment with respect to the states of stress and anhedonia.
Conclusions
In line with available literature, our studies identified dis-
tinct physiological and molecular profiles of anhedonic
and non-anhedonic groups of mice subjected to stress. As
such, the proposed mouse paradigm and other models
which enable the segregation of subpopulation of animals
with and without a depressive-like pattern can be a tool
for addressing the biology of individual susceptibility and
resilience to depression. Besides that, this approach pro-
vides other valuable advantages in modelling of depressive
disorder in animals, as for instance, it allows the differen-
tiation between core and subsidiary depressive features
and let to simulate the co-morbidity of depression and
other stress-related disorders, e.g., anxiety diseases
[78,79,131,132]. This opens new possibilities in pre-clinical
studies aimed at the differentiation between therapeutic
effects of antidepressants to depression symptoms and
other concominant pathological changes. We believe that
data on distinct sensitivity to an antidepressant treatment
of stressed mice with and without depressive-like syn-
drome argue for the validity of our paradigm in mimicking
such clinical aspects of the disorder.
We feel the importance of emphasizing the fact that
the use of internal control in a chronic stress depression
paradigm and behavioural assessment of the validity of
its definition became possible only when the methodol-
ogy of chronic stress model in tested strain of mice was
essentially modified. These modifications mostly con-
cern (1) the sucrose test protocol in mice, the accuracy
of which could be sharply increased to allow distinguish
inter-individual differences in the occurrence of signs of
anhedonia, and (2) the identification and overcoming of
confounds in behavioral testing related to stress-induced
hyperlocomotion. Another feature which appeared to be
important for more accurate group comparison with the
chronic stress model is their balancing upon (3) a per-
centage of individuals with submissive and dominant
social traits, which predicted a susceptibility to a
stressed-induced anhedonia in employed strain.
Together, results discussed here argue for the use of a
subgroup of individuals who are negative for the induc-
tion of a depressive phenotype with experimental para-
digms of depression as an internal control, for more
advanced modeling of this disorder in animals.
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